Novel Agonists & Antagonists for Protease-Activated Receptor 2 and C3a Receptor

doi 10.14264/uql.2017.362
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University of Queensland Library

Related search

Protease-Activated Receptor 2 (PAR2)

Science-Business eXchange
2012English

Erratum To: Protease-Activated-Receptor-2 Affects Protease-Activated-Receptor-1-Driven Breast Cancer

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2016English

Risk of Intracranial Hemorrhage With Protease-Activated Receptor-1 Antagonists

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2012English

Protease-Activated Receptor 1 (PAR1)

Science-Business eXchange
2012English

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

A Polymorphic Protease-Activated Receptor 2 (PAR2) Displaying Reduced Sensitivity to Trypsin and Differential Responses to PAR Agonists

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Acanthamoeba Protease Activity Promotes Allergic Airway Inflammation via Protease-Activated Receptor 2

PLoS ONE
Multidisciplinary
2014English

Design of Subtype Selective Melatonin Receptor Agonists and Antagonists

Reproduction Nutrition Development
1999English

Thrombin Cleaves and Activates the Protease-Activated Receptor 2 Dependent on Thrombomodulin Co-Receptor Availability

Thrombosis Research
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy